Fund Holdings — Darwin Global Management, Ltd.

Total Portfolio Value:
$1.46B
Total Bought:
$530.64M
Total Sold:
$123.34M
Net Transaction:
+$407.30M
Notable People:
Sarah Elizabeth Monime
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)12,960,53815,397,975+2,437,437$894.80M$1.20B82.08%+$306.09M
Verona Pharma PlcADS810,4493,923,204+3,112,755$37.64M$245.98M16.81%+$208.35M
Allogene Therapeutics Inc010,449,791+10,449,791$0$16.20M1.11%+$16.20M
Geron Corporation(GERN)9,569,8350-9,569,835$33.88M$0—-$33.88M
Jazz Pharmaceuticals plcSHS USD(JAZZ)484,5150-484,515$59.67M$0—-$59.67M
Keros Therapeutics, Inc.(KROS)1,687,1350-1,687,135$26.71M$0—-$26.71M
Nurix Therapeutics, Inc.(NRIX)163,6810-163,681$3.08M$0—-$3.08M
Page 1 of 1
Darwin Global Management, Ltd. — 13F Holdings — Q1 2025 | TickerTrail